SCHEMBL7654964

SCHEMBL7654964

O=C(OCc1ccccc1)c1ccc(Oc2ccc([N+](=O)[O-])c(OCc3ccccc3)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.49
RAB9A P51151 2/20 0.49
ALDH1A1 P00352 2/20 0.49
LMNA P02545 1/20 0.48
KMT2A Q03164 3/20 0.48
SLC6A2 P23975 1/20 0.48
SLC6A3 Q01959 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MYC P01106 1/20 0.48
MAX P61244 1/20 0.48
MEN1 O00255 2/20 0.47
NPC1 O15118 1/20 0.46
ATM Q13315 1/20 0.46
CTSV O60911 2/20 0.43
CTSL P07711 2/20 0.43
ABCB1 P08183 1/20 0.43
HPGD P15428 1/20 0.43
BACE1 P56817 1/20 0.43
FFAR1 O14842 1/20 0.43
AKR1C3 P42330 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7152823 0.92 MAPT (0.43) MAPTRAB9AALDH1A1LMNAKMT2A
SCHEMBL7652479 0.89 MAPT (0.43) MAPTRAB9AALDH1A1LMNAKMT2A
SCHEMBL30892476 0.88 MYC (0.55) MAPTRAB9AALDH1A1LMNAKMT2A
SCHEMBL7342938 0.88 MYC (0.55) MAPTRAB9AALDH1A1LMNAKMT2A
SCHEMBL7154482 0.88 KMT2A (0.42) MAPTRAB9AALDH1A1LMNAKMT2A
SCHEMBL646471 0.87 MEN1 (0.54) MAPTRAB9AKMT2ATDP1MYC
SCHEMBL30061165 0.87 MEN1 (0.54) MAPTRAB9AKMT2ATDP1MYC
SCHEMBL7552860 0.87 MEN1 (0.53) MAPTRAB9AKMT2AMYCMAX
SCHEMBL8723001 0.85 L3MBTL1 (0.50) MAPTRAB9AALDH1A1LMNAKMT2A
SCHEMBL7657358 0.85 KMT2A (0.42) MAPTRAB9AALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6437178-B2 REACTING A HALOGENATED BENZENE COMPOUND WITH NITRO(THIO)PHENOL; REDUCTION INFINEON TECHNOLOGIES AG (DE) 2002-08-20 US disclosed
US-20010056203-A1 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid SIEMENS AKTIENGESELLSCHAFT 2001-12-27 US disclosed
US-6310238-B1 INTERMEDIATES FOR THE PREPARATION OF POLYBENZOXAZOLES AND POLYBENZOTHIAZOLES SIEMENS AKTIENGESELLSCHAFT (DE) 2001-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010056203-A1 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid TPMT, PAH, AADAT MAPT 3652/4885RAB9A 4769/4885ALDH1A1 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.